📌 Key Takeaways
- Topic: Silicon Dioxide in Food: Why It Is Added and Whether It Is Safe
- Keywords: silica sol manufacturer
- Published: 2026-11-20 03:52:04
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Hollow Glass Microspheres vs Hollow Silica: Lightweight Fillers Compared
- Silica for HPLC: Particle Types, Pore Sizes and Column Performance
- Lu, M. et al. Location and size regulation of manganese oxides within mesoporous silica for enhanced antibiotic degradation. Chin. J. Chem. Eng. 48, 36-43 (2022). Article CAS Google Scholar
- What Is Fused Silica? Properties, Purity Grades and Uses in Optics and Electronics
- Chen, L., Xu, J., Wang, Y. & Huang, R. Ultra-small MoS 2 nanodots-incorporated mesoporous silica nanospheres for pH-sensitive drug delivery and CT imaging. J. Mater. Sci. Technol. 63, 91-96 (2021). Article CAS Google Scholar
- What Is Hollow Silica? Structure, Properties and Applications
- Ryoo, R., Kim, J., Ko, C. & Shin, C. Disordered molecular sieve with branched mesoporous channel network. J. Phys. Chem. 100, 17718-17721 (1996). Piece CAS Google Scholar
- Silica Matting Agent: How It Works, Key Specs and How to Choose the Right Grade
- Li, Z. & Rong, L. Cascade reaction-mediated productive ferroptosis synergizes with immunomodulation for high-performance cancer therapy. Biomater. Sci. 8, 6272-6285 (2020). Article CAS PubMed Google Scholar
Fused Silica CAS 60676-86-0: Identification, Properties and Safety Data
What is silica (SiO₂)?
silica supplier Huang, C. et al. A dual‐model imaging theragnostic system based on mesoporous silica nanoparticles for enhanced cancer phototherapy. Adv. Healthc. Mater. 8, 1900840 (2019). Piece CAS Google Scholar
What is the difference between fumed silica and precipitated silica?
silica melting point The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
What drives silica raw material prices?
hydrophobic silica powder Tabrizi, M. A. & Acedo, P. Highly sensitive aptasensor for the detection of SARS-CoV-2-RBD utilizing aptamer-gated methylene blue@mesoporous silica film/laser engraved graphene electrode. Biosens. Bioelectron. 215, 114556 (2022). Article Google Scholar
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.